The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II trial comparing different schedules of nab-paclitaxel (nabP) combined with gemcitabine (GEM) as first line treatment for metastatic pancreatic adenocarcinoma (PDAC).
 
Philippa Corrie
Honoraria - Celgene; GlaxoSmithKline; Roche
Consulting or Advisory Role - Baxalta; Bristol-Myers Squibb; Celgene; Merck Sharp & Dohme; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Wendi Qian
No Relationships to Disclose
 
Bristi Basu
Consulting or Advisory Role - Astex Pharmaceuticals; Baxter; Celgene; Nordic Bioscience
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - Bayer
 
Duncan Ian Jodrell
Honoraria - AstraZeneca
Consulting or Advisory Role - 3-V Biosciences; Astex Pharmaceuticals
Research Funding - AstraZeneca; GlaxoSmithKline; Shionogi
Patents, Royalties, Other Intellectual Property - Institute of Cancer Research
Travel, Accommodations, Expenses - Celgene
 
Stephen Falk
Consulting or Advisory Role - Celgene
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene
 
Chinenyu Iwuji
No Relationships to Disclose
 
Harpreet Wasan
Honoraria - Celgene; Merck KGaA
Speakers' Bureau - Celgene; Merck KGaA
Research Funding - Celgene; Merck KGaA
 
Daniel H. Palmer
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Celgene; Nucana; Sirtex Medical
Research Funding - Bayer; Nucana; Sirtex Medical
 
Martin Scott-Brown
No Relationships to Disclose
 
Jonathan Wadsley
No Relationships to Disclose
 
Seema Safia Arif
Honoraria - Bayer; Pierre Fabre
Research Funding - Celgene
Travel, Accommodations, Expenses - Bayer
 
A. Burcu Babaoglan
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene
 
Katy Marie Dalchau
Research Funding - Celgene
 
Aarthi Gopinathan
No Relationships to Disclose
 
Anita Chhabra
No Relationships to Disclose
 
Andrea Machin
No Relationships to Disclose
 
Albrecht Neesse
No Relationships to Disclose
 
David A. Tuveson
Consulting or Advisory Role - Celgene; Gilead Sciences; Infinity Pharmaceuticals; Leap Therapeutics; Merck; Merrimack; Ono Pharmaceutical; Pfizer; Surface Oncology
Research Funding - FibroGen (Inst); Halozyme (Inst); Nichi-iko (Inst)
Patents, Royalties, Other Intellectual Property - Hedgehog inhibitors for drug discovery-CRUK (Inst); imatinib for GIST- Dana Farber (Inst)
 
Juan W. Valle
Honoraria - Advanced Accelerator Applications; AstraZeneca; Baxalta; Celgene; Ipsen; Lilly; Merck; Midatech Pharma; Novartis; Sirtex Medical
Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca; Baxalta; Celgene; Ipsen; Lilly; Merck; Novartis; Sirtex Medical
Speakers' Bureau - Abbott Nutrition; Celgene; Ipsen; Novartis; Pfizer; Sirtex Medical
Research Funding - AstraZeneca (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis